Home > SANTE - SCIENCES DE LA VIE > Industrie Pharmaceutique > Oncologie > Oncology market in Japan ...
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS

Oncology market in Japan and USA

 
Anglais, PDF, Janvier 2002, 34 pages
TRANSFERER
AJOUTER AUX FAVORIS




 
 
   
Secteur analysés : cancer,breast cancer,chemotherapy,lymphoma,...,...
Type d'analyse : market size and estimates,market outlook,...
Marché traités : japan,usa,china,germany,switzerland
   
Essayez une nouvelle recherche :
 
 
Votre E-mail:
Votre Mot de Passe :
  €39
 




 
Email:
Choisissez un mot de passe:
Confirmez votre mot de passe:
 
compound,  phosphate,  pipeline,  polyethylene,  sachet,  sodium,  anxiety,  breast cancer,  cancer,  cancer treatment,  cancer drug,  central nervous system,  cervical cancers,  chemotherapy,  clinical trials,  cns,  contraception,  cytotoxic,  fatty acids,  financials,  gastric cancer,  healthcare,  hepatitis c,  hypertension,  immunology,  infusion,  insomnia,  kidney transplantation,  lung cancer,  lymphoma,  metabolic diseases,  monoclonal antibodies,  monoclonal antibody,  oncology,  osteoarthritis,  osteoporosis,  otc,  parkinson,  pharmaceutical,  pharmaceuticals,  pharmacoeconomics,  phosphate,  polyethylene,  psoriasis,  sepsis,  sleep disorders,  stem cell,  urinary incontinence,  vitamin,  vitamins,  
rjapanj investor relations 020129 nr_booklet_020129_4 doc088684 29 jan 2002 23 13 1 34 january disclaimer this booklet contains certain forward looking statements these may be identified by words such as believes expects anticipates projects intends should seeks estimates future or similar expressions discussion of strategy goals plans intentions various factors cause actual results to differ materially in the from those reflected contained among others pricing and product initiatives competitors 2 legislative regulatory developments economic conditions 3 delay inability obtaining approvals bringing products market 4 fluctuations currency exchange rates general financial 5 uncertainties discovery development marketing new uses existing 6 increased government pressures 7 interruptions production 8 loss obtain adequate protection for intellectual property rights 9 litigation 10 key executives other employees 11 adverse publicity news coverage level disclosure information otherwise that on an individual company represents exception
>> Marché Environnement en France >>
 
DPLSEN
New Search:
© Plusdetudes 2007